CERAVE DEVELOPED WITH DERMATOLOGISTS ACNE CONTROL ACNE TREATMENT- salicylic acid gel 
L'Oreal USA Products Inc

----------

Drug Facts

Active ingredient

Salicylic acid 2%

Purpose

Acne treatment

Uses

Warnings

For external use only

When using this product

skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. if irritation occurs, only use one topical acne medication at a time.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• clean the skin thoroughly before applying this product
• cover the entire affected area with a thin layer one to three times daily
• because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
• if bothersome dryness or peeling occurs, reduce application to once a day or every other day

Other information

• store at 20 – 25ºC (68 – 77ºF)
• protect from excessive moisture

Inactive ingredients

water, glycerin, sodium hydroxide, glycolic acid, lactic acid, niacinamide, ceramide NP, ceramide AP, ceramide EOP, carbomer, cetearyl alcohol, behentrimonium methosulfate, triethyl citrate, sodium hyaluronate, sodium lauroyl lactylate, cholesterol, chlorphenesin, disodium EDTA, hydroxypropyl guar, caprylyl glycol, xanthan gum, phytosphingosine, benzoic acid

image of a label

image of a label
CERAVE DEVELOPED WITH DERMATOLOGISTS ACNE CONTROL ACNE TREATMENT 
salicylic acid gel
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49967-172
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Salicylic Acid (UNII: O414PZ4LPZ) (Salicylic Acid - UNII:O414PZ4LPZ) Salicylic Acid20 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
GLYCERIN (UNII: PDC6A3C0OX)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
GLYCOLIC ACID (UNII: 0WT12SX38S)  
LACTIC ACID (UNII: 33X04XA5AT)  
NIACINAMIDE (UNII: 25X51I8RD4)  
CERAMIDE NP (UNII: 4370DF050B)  
CERAMIDE AP (UNII: F1X8L2B00J)  
CERAMIDE 1 (UNII: 5THT33P7X7)  
CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
BEHENTRIMONIUM METHOSULFATE (UNII: 5SHP745C61)  
TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
SODIUM LAUROYL LACTYLATE (UNII: 7243K85WFO)  
CHOLESTEROL (UNII: 97C5T2UQ7J)  
CHLORPHENESIN (UNII: I670DAL4SZ)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
GUARAPROLOSE (1300 MPA.S AT 1%) (UNII: 1530WMS90S)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
XANTHAN GUM (UNII: TTV12P4NEE)  
PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q)  
BENZOIC ACID (UNII: 8SKN0B0MIM)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:49967-172-011 in 1 CARTON05/18/2021
140 mL in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00605/18/2021
Labeler - L'Oreal USA Products Inc (002136794)
Establishment
NameAddressID/FEIBusiness Operations
L'OREAL USA PRODUCTS, INC.624244349manufacture(49967-172) , pack(49967-172)

Revised: 12/2023
Document Id: dc3ff666-19b7-4146-8eed-e28b7689274d
Set id: 2532352e-eabc-4565-9437-b8801db6937a
Version: 2
Effective Time: 20231231
 
L'Oreal USA Products Inc